| Ki | - |
| EC50 | - |
| IC50 | - |
| Inhibition | - |
| Toxicity | - |
| ROS(reactive oxygen species) | - |
| Metal Chelating | - |
| BBB(blood-brain barrier) | - |
| Target Protein | Monoamine Oxidase B (MAOB) |
| Effects | - |
| Research Models | - |
| Ref. Link |
| Molecular Weight(Computed by SwissADME) | |
| Hac(Computed by SwissADME) | |
| Volume(Computed by ADMETlab 2.0) | |
| Density(Computed by ADMETlab 2.0) | |
| nRing(Computed by ADMETlab 2.0) | |
| MaxRing(Computed by ADMETlab 2.0) | |
| nHet(Computed by ADMETlab 2.0) | |
| fChar(Computed by ADMETlab 2.0) | |
| nRig(Computed by ADMETlab 2.0) | |
| Flexibility(Computed by ADMETlab 2.0) | |
| Stero Centers(Computed by ADMETlab 2.0) | |
| LogS(Computed by ADMETlab 2.0) | |
| LogD(Computed by ADMETlab 2.0) |
| logP(Computed by ADMETlab 2.0) | |
| TPSA(Computed by SwissADME) | |
| Hbond Acceptor(Computed by SwissADME) | |
| Hbond Donor(Computed by SwissADME) | |
| Rotatable Bonds(Computed by SwissADME) |
| GI Absorption(Computed by SwissADME) | |
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | |
| P-gp Substrate(Computed by SwissADME) | |
| CYP1A2 Inhibitor(Computed by SwissADME) | |
| CYP2C19 Inhibitor(Computed by SwissADME) | |
| CYP2C9 Inhibitor(Computed by SwissADME) | |
| CYP2D6 Inhibitor(Computed by SwissADME) | |
| CYP3A4 Inhibitor(Computed by SwissADME) | |
| log Kp(Skin Permeation)(Computed by SwissADME) |
| Lipinski(Computed by SwissADME) | |
| Ghose(Computed by SwissADME) | |
| Veber(Computed by SwissADME) | |
| Egan(Computed by SwissADME) | |
| Muegge(Computed by SwissADME) | |
| Bioavailability Score(Computed by SwissADME) |